[HTML][HTML] Therapeutic effects of Crataegus monogyna inhibitors against breast cancer

GM Basavarajappa, A Rehman… - Frontiers in …, 2023 - frontiersin.org
Breast cancer is a silent killer disorder among women and a serious economic burden in
healthcare management. Every 19 s, a woman is diagnosed with breast cancer, and every …

[HTML][HTML] Anhydroicaritin inhibits EMT in breast cancer by enhancing GPX1 expression: A research based on sequencing technologies and bioinformatics analysis

F Li, Y Shi, X Yang, Z Luo, G Zhang, K Yu… - Frontiers in Cell and …, 2022 - frontiersin.org
Background: Breast cancer (BC) is the leading cause of cancer-related deaths among
women worldwide. The application of advanced technology has promoted accurate …

Exploring the mechanism of Cremastra Appendiculata (SUANPANQI) against breast cancer by network pharmacology and molecular docking

L Zhang, K Yang, M Wang, L Zeng, E Sun… - … Biology and Chemistry, 2021 - Elsevier
Background SUANPANQI, the pseudo phosphorous stem of Cremastra appendiculata, is
one of the most well-known traditional Chinese medicine, which has been shown to inhibit …

[HTML][HTML] Identifying the effect of ursolic acid against triple-negative breast cancer: coupling network pharmacology with experiments verification

Y Zhang, X Ma, H Li, J Zhuang, F Feng, L Liu… - Frontiers in …, 2021 - frontiersin.org
Triple negative breast cancer (TNBC) is a subtype of breast cancer with complex
heterogeneity, high invasiveness, and long-term poor prognosis. With the development of …

[HTML][HTML] Predicted molecular targets and pathways for germacrone, curdione, and furanodiene in the treatment of breast cancer using a bioinformatics approach

Q Kong, Y Ma, J Yu, X Chen - Scientific Reports, 2017 - nature.com
Germacrone, curdione, and furanodiene have been shown to be useful in the treatment of
breast cancer but the pharmacological mechanism of action is unclear. In this paper, we …

Tracing the pathways and mechanisms involved in the anti-breast cancer activity of glycyrrhizin using bioinformatics tools and computational methods

A Poustforoosh, S Faramarz… - Journal of …, 2024 - Taylor & Francis
A complete investigation to understand the pathways that could be affected by glycyrrhizin
(licorice), as anti-breast cancer (BC) agent, has not been performed to date. This study aims …

[HTML][HTML] Exploring the Regulation Mechanism of Xihuang Pill, Olibanum and β-Boswellic Acid on the Biomolecular Network of Triple-Negative Breast Cancer Based …

K Yang, L Zeng, A Ge, T Bao, T Xu, X Xie… - Frontiers in …, 2020 - frontiersin.org
Background Xihuang Pill (XHP) is mainly used to treat “Ru Yan (breast cancer)”. Evidence-
based medical evidence and showed that XHP improves the efficacy of chemotherapy and …

[HTML][HTML] Mechanistic elucidation of Juglanthraquinone C targeting breast cancer: a network pharmacology-based investigation

H Qayoom, M Alkhanani, A Almilaibary… - Saudi Journal of …, 2023 - Elsevier
Breast cancer is the leading cause of death among women worldwide. Despite the recent
treatment options like surgery, chemotherapy etc. the lethality of breast cancer is alarming …

[HTML][HTML] Analyzing the multi-target pharmacological mechanism of folium Artemisia argyi acting on breast cancer: a network pharmacology approach

Y Song, J Wang, X Wang, H Zhang, X Niu… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Folium Artemisia argyi (FAA) is a traditional Chinese herbal medicine that is
widely used in the clinic. However, the underlying mechanisms of its anticancer effects have …

[HTML][HTML] Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on …

WR Mir, BA Bhat, A Kumar, R Dhiman… - Frontiers in …, 2023 - frontiersin.org
Delphinium roylei Munz is an indigenous medicinal plant to India where its activity against
cancer has not been previously investigated, and its specific interactions of bioactive …